The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of daratumumab + SOC versus SOC in myeloma induction regimens, by risk-stratification: Meta-analysis of phase III randomized control trials.
 
Nisha Joseph
No Relationships to Disclose
 
Craig C. Hofmeister
Consulting or Advisory Role - Celgene; Imbrium Therapeutics; Janssen Oncology; Karyopharm Therapeutics; Nektar; Oncopeptides; Sanofi Pasteur
Research Funding - Bristol-Myers Squibb; Celgene; Celularity
 
Madhav V. Dhodapkar
Consulting or Advisory Role - Amgen; Celgene; Janssen Oncology; Kite, a Gilead company; lava therapeutics; Roche/Genentech
 
Lawrence Boise
Honoraria - AstraZeneca
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca
Research Funding - AstraZeneca (Inst)
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
 
Madhusmita Behera
No Relationships to Disclose
 
Jonathan L. Kaufman
Honoraria - Tecnofarma
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Takeda; Tecnofarma; TG Therapeutics
Research Funding - Abbvie/Genentech (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Fortis (Inst); Janssen (Inst); Merck (Inst); Sutro Biopharma (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Sanofi; Takeda
 
Ajay K. Nooka
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Spectrum Pharmaceuticals; Takeda
Research Funding - Amgen (Inst); Janssen Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline